Posted by Michael Wonder on 28 Jul 2016
EMA publishes EPAR for Epclusa (sofosbuvir with velpatasvir)
28 July 2016 - The EMA has published an EPAR for Gilead's Epclusa.
The European Commission approved Epclusa on 6 July 2016 for the treatment of chronic hepatitis C virus infection in adults.
Epclusa will be subjected to additiional monitoring by the EMA.
